Treatment of non-obese diabetic (NOD)/severe-combined immunodeficiency mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells

Blood

Volumn 92, Issue 6, 1998, Pages 2024-2031

  Kapp, Ursula ^b   Bhatia, Mickie ^b   Bonnet, Dominique ^b   Murdoch, Barbara ^b   Dick, John E ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL POPULATION; CELL TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; T LYMPHOCYTE;

EID: 0032530741     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.6.2024.418k12_2024_2031     Document Type: Article

References (34)

1. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE: Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137, 1992
2. Larochelle A, Vormoor J, Lapidot T, Sher G, Furukawa T, Li Q, Shultz LD, Olivieri NF, Stamatoyannopoulos G, Dick JE: Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum Mol Genet 4:163, 1995
3. Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE, Dick JE: Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 83:2489, 1994
4. Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I, Williams DA, Dick JE: Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 2:1329, 1996
5. Dick JE: Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol 8:197, 1996
6. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE: Purification of primitive human hematopoietic cells capable of repopulating immunedeficient mice. Proc Natl Acad Sci USA 94:5320, 1997
7. Hogan CJ, Shpall EJ, McNulty O, McNiece I, Dick JE, Shultz LD, Keller G: Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 90:85, 1997
8. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L: Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cordblood mononuclear cells. Blood 88:3731, 1996
9. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Kelner G, Namikawa R, Rennick D, Roncarolo MG, Zlotnik A, Rosnet O, Dubreull P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
10. Jacobsen SE, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD: The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: Synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357, 1995
11. Lyman SD, James L, Vanden B-T, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah T, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
12. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR: Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147, 1995
13. Brasel K, McKenna HJ, Morrissey PJ, Charrier K, Morris AE, Lee CC, Williams DE, Lyman SD: Hematologic effects of flt3 ligand in vivo in mice. Blood 88:2004, 1996
14. Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S, Peschle C: Multi-level effects of flt3 ligand on human hematopoiesis: Expansion of putative stem cells and proliferation of granulomonocytic progenitors/ monocytic precursors. Blood 86:1661, 1995
15. Lyman SD, James L, Johnson L, Brasel K, de V-P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
16. McKenna HJ, de V-P, Brasel K, Lyman SD, Williams DE: Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells. Blood 86:3413, 1995
17. Rusten LS, Lyman SD, Veiby OP, Jacobsen SE: The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro. Blood 87:1317, 1996
18. McNiece IK, Briddell RA: Stem cell factor. J Leukoc Biol 58:14, 1995
19. Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, Civin CI: STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
20. Brasel K, Escobar S, Anderberg R, de V-P, Gruss HJ, Lyman SD: Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212, 1995
21. Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE: The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta. J Immunol 157:2953, 1996
22. Hunte BE, Hudak S, Campbell D, Xu Y, Rennick D: flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol 156:489, 1996
23. Namikawa R, Muench MO, de V-JE, Roncarolo MG: The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 87:1881, 1996
24. Henney CS: Interleukin 7: Effects on early events in lymphopoiesis. Immunol Today 10:170, 1989
25. Rich BE, Leder P: Transgenic expression of interleukin 7 restores T cell populations in nude mice. J Exp Med 181:1223, 1995
26. Jacobsen FW, Veiby OP, Skjonsberg C, Jacobsen SE: Novel role of interleukin 7 in myelopoiesis: Stimulation of primitive murine hematopoietic progenitor cells. J Exp Med 178:1777, 1993
27. Jacobsen FW, Rusten LS, Jacobsen SE: Direct synergistic effects of interleukin-7 on in vitro myelopoiesis of human CD34+ bone marrow progenitors. Blood 84:775, 1994
28. Fahlman C, Blomhoff HK, Veiby OP, McNiece IK, Jacobsen SE: Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro. Blood 84:1450, 1994
29. Grzegorzewski K, Komschlies KL, Mori M, Kaneda K, Usui N, Flatynek CR, Keller JR, Ruscetti FW, Wiltrout RH: Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites. Blood 83:377, 1994
30. Damia G, Komschlies KL, Flatynek CR, Ruscetti FW, Wiltrout RH: Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice. Blood 79:1121, 1992
31. Morrissey PJ, Conlon P, Braddy S, Williams DE, Namen AE, Mouchizuki DY: Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. J Immunol 146:1547, 1991
32. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181:1519, 1995
33. Veiby OP, Lyman SD, Jacobsen SE: Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood 88:1256, 1996
34. Shah AJ, Smogorzewska EM, Hannum C, Crooks GM: Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38-cells and maintains progenitor cells in vitro. Blood 87:3563, 1996